Indonesia vs United Arab Emirates: Previously treated cases tested for RR-/MDR-TB
Indonesia
83.0%
in 2024
United Arab Emirates
83.0%
in 2024
Indonesia rank
104th
United Arab Emirates rank
104th
Previously treated cases tested for RR-/MDR-TB over time
- Indonesia
- United Arab Emirates
How they compare
Indonesia currently reports 83.0% against 83.0% in United Arab Emirates, a difference of 0.0%.
The two have swapped places 3 times across 13 shared years of data; in 2011 it was Indonesia ahead.
Indonesia ranks 104th and United Arab Emirates ranks 104th of 180 countries.
Across the 2 decades both report, Indonesia averaged higher in 1 and United Arab Emirates in 1.
Head to head by decade
| Decade | Indonesia | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 69.8% | 69.4% | 0.3% | Indonesia |
| 2020s | 85.8% | 89.5% | 3.8% | United Arab Emirates |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Indonesia or United Arab Emirates?
- Indonesia, at 83.0% against 83.0% in United Arab Emirates as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Indonesia and United Arab Emirates?
- 0.0%, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and United Arab Emirates?
- 13 years are reported by both, from 2011 to 2024.
- How do Indonesia and United Arab Emirates rank globally for previously treated cases tested for rr-/mdr-tb?
- Indonesia ranks 104th and United Arab Emirates ranks 104th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.